Catalyst Capital Advisors’s Select Medical SEM Stock Holding History

Catalyst Capital Advisors’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-22,662	Closed	-$416K	–	401
2021 Q1	$416K	Hold	22,662	–	–	0.02%	188
2020 Q4	$338K	Hold	22,662	–	–	0.02%	203
2020 Q3	$254K	Buy	+22,662	New	+$223K	0.01%	219

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Catalyst Capital Advisors's SEM Position: Q2 2021 in Review

Catalyst Capital Advisors sold out of Select Medical (SEM) in Q2 2021, closing a stake of 22,662 shares — an estimated $416K sold.

Catalyst Capital Advisors first reported a position in SEM in Q3 2020 and held it in 3 quarters. The position peaked at $416K in Q1 2021. 264 funds tracked by Wall St. Rank hold SEM as of Q2 2021.

Catalyst Capital Advisors reported no remaining Select Medical position as of Q2 2021 after selling out during the quarter.
Catalyst Capital Advisors sold 22,662 Select Medical shares in Q2 2021, an estimated $416K.
Catalyst Capital Advisors first reported a position in Select Medical in Q3 2020 and held it in 3 quarters.
Catalyst Capital Advisors's Select Medical position peaked at $416K in Q1 2021.
264 funds tracked by Wall St. Rank held Select Medical as of Q2 2021.

Based on Catalyst Capital Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.